Home / Contract Awards / CDC Awards Emergent BioSolutions New Anthrax Vaccine Development Funds

CDC Awards Emergent BioSolutions New Anthrax Vaccine Development Funds

medical health doctorThe Department of Health and Human Services has tapped Emergent BioSolutions to further develop a new anthrax vaccine under a 30-month, $31 million contract with funding and technical support from the Biomedical Advanced Research and Development Authority.

HHS said Monday the new vaccine, called NuThrax, will work to improve on the existing licensed vaccine as the agency seeks to reduce number of needed doses to deliver protection against anthrax.

“Anthrax remains a national health security threat, and we’re striving to develop an anthrax vaccine that affords immunity sooner and with fewer doses, ” said BARDA Director Robin Robinson.

“If it works, this vaccine may help achieve better preparedness at a lower cost.”

According to HHS, NuThrax is a modification of Emergent’s BioThrax vaccine, which is licensed by the U.S. Food and Drug Administration and stockpiled by the Centers for Disease Control and Prevention.

The department noted that previous tests on NuThrax, which includes CPG 7909 to further stimulate the immune system, indicated that only two doses are needed compared to BioThrax’s three doses.

The new agreement with Emergent announced by Nicole Lurie, assistant secretary for preparedness and response at HHS, moves the new vaccine from early development under the National Institute of Allergy and Infectious Diseases and the Defense Department to advanced development under BARDA.

Check Also

Avon Rubber Books $333M Body Armor Supply Contract With DLA

The Defense Logistics Agency has selected U.K.-based protective equipment supplier Avon Rubber for a potential  $333M framework contract to provide body armor plates from its recently acquired business, Ceradyne.

Aerospace Defense Firms Launch Measures to Avoid COVID-19 Spread; Ellen Lord Quoted

Boeing (NYSE: BA), Textron’s (NYSE: TXT) Bell subsidiary and other aerospace defense manufacturers have increased cleaning efforts and implemented telework capabilities, social distancing and other measures to prevent the spread of the coronavirus and maintain operations, FlightGlobal reported Friday. Other companies that have initiated similar efforts are Lockheed Martin (NYSE: LMT), Northrop Grumman (NYSE: NOC), Sikorsky and AeroVironment.